McDermott Will & Emery Health Law Podcast: Recent Episodes
McDermott Will & Emery
Listen to the industry’s leading health and life sciences lawyers as they share their perspectives on a range of topics impacting the healthcare sector. From emerging legal developments, transaction trends and industry innovation, the McDermott Will & Emery Health Law podcast addresses key insights to help you fuel your mission.
In this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group is joined by Joel White, Partner at Monument Advocacy, leading their health practice and President of the Council for Affordable Health Coverage (CAHC), to discuss the healthcare policy changes shaping Washington and what they could mean for the industry.
Brian and Joel explore the legislative outlook ahead of the midterm elections, including healthcare affordability, Medicare physician payment, drug pricing reform, and the prospects for additional reconciliation legislation. They also examine the growing focus on healthcare consolidation, competition, and antitrust enforcement, highlighting the policy shifts that could reshape healthcare delivery and reimbursement in the years ahead. Tune in for an insider's perspective on the evolving policy landscape and the key healthcare changes stakeholders should be watching.
In this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group is joined by Dan Beuerlein, Managing Director at Brentwood Capital Advisors, and Kyle West, CEO of Behavioral Framework, for a discussion on the evolving autism therapy services market and the future of applied behavior analysis (ABA).
Together, they explore the strong investor interest driving autism services M&A, the workforce strategies helping providers scale, and the innovations transforming care delivery, from clinician development and AI-enabled operations to individualized treatment models and expanding care continuums. The conversation also examines payer expectations, reimbursement trends, and how leading providers are adapting to a more sophisticated regulatory and operational environment.
In this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group sits down with Erika Haanpaa, Managing Director at Cain Brothers, a division of KeyBanc Capital Markets, to discuss the current state of behavioral health M&A. Together, they explore why investor interest remains strong despite a more measured transaction environment, what distinguishes high-quality assets in today's market, and how buyers and sellers are navigating evolving reimbursement dynamics, labor challenges, and operational complexity.
Tune in for an insightful discussion on transaction trends, emerging opportunities across behavioral health subsectors, and why the sector's long-term fundamentals continue to support investment and growth.
In this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group is joined by Jeanne Proia, Managing Director and President of Healthcare Services at Cross Keys Capital, to discuss the evolving M&A landscape across physician practice management (PPM), ambulatory surgery centers (ASCs), and outpatient services. Together, they explore improving market sentiment, valuation expectations, and the specialties attracting the most investor interest, including oncology, ophthalmology, pain management, anesthesia, and infusion services.
Jeanne also shares her perspective on today's more disciplined diligence environment, the impact of evolving state regulatory requirements, and the trends shaping healthcare services transactions through the remainder of the year.
In this episode of Driving the Deal, Brian Fortune, Senior Managing Director of Farragut Square Group, is joined by Hope Amsterdam, Vice President at Farragut Square Group, and Jeffrey Davis, Senior Director at McDermott+ and author of Regs & Eggs, to unpack the 2027 Medicare Advantage final rate announcement and the policy debates shaping the future of the program.
The conversation covers the dramatic shift from the initial proposed flat update to the stronger final rate increase, the ongoing evolution of risk adjustment and V28, and what CMS's approach signals for MA plans moving forward. The group also discusses enrollment trends, plan strategy, auto-enrollment concepts, and emerging policy questions around Part D and GLP-1 coverage.
Tune in for a timely discussion on one of the most closely watched healthcare policy developments of the year.
In this episode of Driving the Deal, Brian Fortune, Senior Managing Director of Farragut Square Group is joined by Hope Amsterdam, Vice President at Farragut Square Group, and Jeffrey Davis, Senior Director at McDermott+ and author of Regs & Eggs, for a recap of the major CMS spring regulatory updates impacting providers across the healthcare landscape.
Together, they break down key developments in hospice, skilled nursing, inpatient psych, and hospital payment policy, including FY rate updates, evolving CMS oversight priorities, and the proposed nationwide expansion of the CJR model.
The conversation also explores what these rules signal about the future of value-based care, mandatory payment models, and regulatory direction heading into the next rulemaking cycle.
Employer-sponsored healthcare is quickly becoming one of the most active areas in healthcare M&A.
In this episode of Driving the Deal, host Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Trey Marinello, Managing Director in Houlihan Lokey's Healthcare Group, and by colleague, Kate McDonald, Partner and co-chair of McDermott Will & Schulte's managed care group.
The group discusses where capital is flowing across the employer health ecosystem, including TPAs, cost containment, and alternative health plans, as well as forces shaping the market, from rising pharmacy spend and GLP-1s to AI-driven underwriting and evolving distribution models.
The conversation also covers valuation trends and post-deal strategies that are helping companies scale in an increasingly competitive landscape.
In this episode of Driving the Deal, host Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Dudley Baker and Luiz Greca, Managing Directors in Houlihan Lokey's Healthcare Group and co-leads of the firm's Healthcare Technology (HCIT) practice.
Framed around where AI is productive, disruptive, and overhyped, the conversation explores how AI is driving efficiencies across administrative workflows, revenue cycle management, and payer operations, while also becoming a key diligence and valuation consideration in nearly every deal.
The group also discusses where disruption is happening today, the importance of systems of record like EMRs, and why much of the broader AI narrative in healthcare remains overstated.
This special series of the Governing Health podcast with SullivanCotter highlights developments in physician compensation governance and offers insight to healthcare organizations navigating the complex regulatory landscape of physician compensation arrangements. In this episode, Monica Wallace, Partner at McDermott Will & Schulte, and Tom Trachtman, Principal at SullivanCotter, discuss how organizations can build mature, defensible governance frameworks in an era of heightened enforcement. They explore the "Big Three" federal laws (Physician Self-Referral Law a/k/a the Stark Law, Anti-Kickback Statute, and False Claims Act) and provide guidance on dual-committee oversight, fair market value standards, and governance practices that balance compliance with strategic goals.
In this episode of Driving the Deal, host Brian Fortune, Senior Managing Director at Farragut Square Group, unpacks McDermott Will & Schulte's HPE Miami 2026 Conference, with Scott Kremeier, Managing Director at Piper Sandler. Together, they discuss what they saw on the ground in Miami and what it means for the rest of 2026.
They dive into:
- A noticeable shift in investor sentiment
- Rising pitch activity and a steady return of deals to market
- Renewed interest in healthcare services after a quieter stretch
- Why middle-market activity is leading the rebound
- How AI is driving efficiency
From valuation resets to capital deployment pressures, the episode highlights why the market may be entering a new, more active phase.
In this episode of Driving the Deal, host Brian Fortune, Senior Managing Director at Farragut Square Group, welcomes L.A. Galyon IV, Managing Partner, and Burk Lindsey, Managing Director, of Brentwood Capital Advisors to explore where healthcare M&A activity is gaining real traction.
They dive into the sectors driving momentum, particularly behavioral health and post-acute care, and unpack why supply-demand imbalances, evolving care models, and labor dynamics are shaping investment decisions. The conversation also touches on trends in outpatient care, hybrid delivery models, and how investors are approaching growth in still-developing segments of the market.
On this episode of Driving the Deal, host Brian Fortune, Senior Managing Director at Farragut Square Group, speaks with Martha Lawrence, CEO and Co-Founder of AccendoWave, a machine learning healthcare technology company focused on objectively measuring and managing pain.
They discuss how brainwave-based data can transform pain measurement, address bias in care, and create new opportunities across healthcare, from hospitals and cancer care to workers' compensation and women's health. The conversation also explores how objective pain data could impact providers, payers, and healthcare investors.
In this episode of Driving the Deal, host Brian Fortune, Senior Managing Director at Farragut Square Group, speaks with Todd Rudsenske, Managing Director at Cain Brothers, about emerging trends shaping the behavioral health market. Behavioral health has been a major focus for investors for more than a decade, but the sector is entering a new phase.
They discuss the rise of digital mental health tools, increasing provider specialization, evolving payment models, and how technology and traditional providers may converge in the next wave of behavioral health M&A.
In this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, welcomes Hector Torres, Managing Director of DC Advisory's global healthcare team, for a conversation on the evolving healthcare M&A landscape. Drawing on more than two decades of healthcare investment banking experience, Hector shares insights into current investor sentiment, the state of deal activity, and the macro factors shaping healthcare services and related sectors. The discussion also explores how strategic buyers and private equity investors are approaching deployment, scale, and opportunity in a shifting market environment.
Note: This conversation was recorded toward the end of 2025.
In this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, sits down with Rebecca Springer, Director of Market Development at Bailey & Company, to discuss the rapid rise of Individual Coverage Health Reimbursement Arrangements (ICHRAs).
They break down how ICHRAs work, why adoption is accelerating across employers of all sizes, and what the model means for healthcare costs, employee choice, and benefits strategy. The conversation also explores the expanding ICHRA ecosystem, including administrators, brokers, carriers, and HR platforms, and why the space is increasingly on the radar of private equity investors. Finally, Rebecca provides an update on recent policy and market developments, including ACA subsidy changes, state-level activity, and what these shifts could mean for ICHRA growth in the year ahead.
This podcast was recorded and is for informational purposes only. By accessing this podcast, you acknowledge that Bailey & Co. makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of Bailey & Co. This podcast should not be used as a substitute for competent investment advice from a licensed professional in your state and should not be construed as an offer to make or consider any investment or course of action.
In this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, welcomes David W. Johnson, CEO of 4sight Health and co-author of The Coming Healthcare Revolution: 10 Forces That Will Cure America's Health Crisis. Together, they discuss the ideas behind the book and why the U.S. healthcare system is approaching a period of unprecedented change.
Johnson breaks down the major forces reshaping healthcare, from demographics and chronic disease to AI, synthetic biology, and pro-consumer reforms, and explains why the next decade may bring more disruption than the last century. The conversation explores care redesign, cost pressures on hospitals, pricing transparency, and what it will take to build a healthcare system that delivers better outcomes, lower costs, and a better patient experience.
As the Driving the Deal kicks off the new year, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Vikram Sithian, Managing Director and Head of Healthcare Financial Sponsors Coverage at Cantor. They offer a look back at the key dynamics that shaped the 2025 healthcare deal market while setting the stage for what's ahead in 2026. They discuss the most active healthcare services and HCIT subsectors, shifts in valuation multiples, real-world AI use cases, evolving financing structures, and EBITDA size dynamics. The conversation also explores what sponsors should be preparing for as monetizations and exits come back into focus in the year ahead. This episode is a must listen as the new year begins!
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by colleague and Assistant Vice President, Holly Stokes, an expert in health policy, for a deep dive into the CY 2026 Physician Fee Schedule. In this episode, Brian and Holly break down the latest updates from CMS, highlighting how the finalized 2026 varies very little from the proposed rule, compares to previous years, and their potential impact on healthcare providers. From winners and losers under the new reimbursement structure to the future of primary care allocations and hot topics like skin substitutes and practice expense adjustments, the conversation offers clear, insightful analysis on what healthcare stakeholders need to know heading into 2026.
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Sharon Lamb, Head of McDermott's UK Healthcare Practice Group. They unpack key themes from McDermott's HPE Europe 2025 and explore the event's biggest takeaways from shifting global policies on drug pricing and the boom in Chinese biotech, to AI's growing role in R&D, supply chain dynamics, and the renewed investor focus on healthcare services heading into 2026.
As they look ahead to the Jefferies Global Healthcare Conference in London next week, the conversation offers an insider's view on how policy, innovation, and capital are converging to redefine the future of healthcare investment.
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Ben Wanamaker, Operating Partner at General Atlantic to discuss how the One Big Beautiful Bill Act (OBBBA) is reshaping the Medicaid landscape. Ben breaks down OBBBA's major provisions like work requirements, redeterminations, provider tax reductions, and cost-sharing rules and their implications for enrollment, member engagement, and provider payments.
The conversation also explores:
-
How value-based care remains central to Medicaid innovation.
-
The importance of adaptability in a highly regulated, state-driven environment.
-
Why innovation and data analytics are critical for staying competitive.
-
The deal market outlook for Medicaid-focused providers and investors amid policy uncertainty.
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Cary Gibson, founder of Gibson Health Policy and longtime Washington policy expert, to unpack the latest developments shaping the pharmaceutical landscape. From the Trump administration's push to lower drug prices and the revival of "most favored nation" pricing concepts, to state-level prescription drug boards and 340B reform debates, Cary offers sharp insights on where the pressure points are and what's next for the industry.
This special series of the Governing Health podcast with SullivanCotter highlights developments in and offers support to the board's executive compensation committee in light of the many complex operational, technical, and strategic issues that the committee confronts.
In this episode, Michael Peregrine, Bruce Greenblatt, Kathy Hastings, John Collins, Kerrin Slattery, and Jeff Holdvogt discuss why innovative compensation incentives are a hot topic for health systems clients and their compensation committees.
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Monica Wallace, Partner at McDermott Will & Schulte and a leader of the firm’s Healthcare Regulatory & Compliance practice. Monica breaks down the rise in government healthcare audits, the use of extrapolated overpayments, and how providers can prepare. Together, they discuss avoiding overproduction of documents, getting legal and billing experts involved early, and acting quickly on audit letters to protect appeal rights. The episode also covers how audit history impacts M&A deals and why compliance readiness is more important than ever.
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Matt Menendez, President of White Plume Technologies, to explore how AI is reshaping mid-revenue cycle management. They dive into trends in the PPM space, the rising importance of operational efficiency, and how AI is empowering coders with "superpowers" rather than replacing them. From silent revenue failures to front-end automation, learn how AI is driving real EBITDA gains per provider and what to expect in the years ahead.
In this episode of Driving the Deal, host Brian Fortune, Senior Managing Director at Farragut Square Group, is joined again by Rodney Whitlock, Vice President at McDermott+ and longtime Capitol Hill health policy expert for a rapid-fire Medicaid update recorded Friday, June 27. As the Senate eyes a final vote on the “One Big Beautiful Bill” Act (OBBBA), Rodney offers a real-time look at where things stood at the end of the week. They break down the Senate parliamentarian’s rulings striking several Medicaid provisions, including restrictions on eligibility and changes to provider taxes, and what remains in play, such as work requirements and rural hospital protections. Brian and Rodney also explore why a recent White House memo on state-directed payments may pose an even greater challenge than the bill itself. With pre-conferencing already underway and a final Senate vote expected as soon as tonight (June 30), Rodney walks us through the procedural path ahead. So, if you’re tracking the future of Medicaid funding, state flexibility, or the broader OBBB package, this episode delivers the timely insights you need.
In our final episode of our McDermott HealthEx series, Brian Fortune, Senior Managing Director at Farragut Square Group, and Krist Werling, Partner & Global Head of Health & Life Sciences at McDermott Will & Emery, welcome Robbie Allen, CEO of US Heart & Vascular, for a candid conversation on the state of physician practice management. They explore the shifting dynamics of the PPM market, what it takes to build a truly integrated and high-performing platform, and how evolving physician expectations, new tech, and regulatory pressures are shaping the future of the space.
In our third episode of our HealthEx series, live from the inaugural McDermott HealthEx conference in Nashville, TN, Brian Fortune, Senior Managing Director at Farragut Square Group, and Krist Werling, Partner & Global Head, Health & Life Sciences at McDermott Will & Emery, are joined by Gaurav Bhattacharyya, Chief Executive Officer of Geode Health, and Amanda Jester, Partner at McDermott Will & Emery. The group dives into the evolving behavioral health landscape, including consolidation trends, access and reimbursement challenges, workforce dynamics, and the future of value-based care. They also explore how AI is enhancing administrative efficiency while maintaining the importance of human connection in care delivery.
We continue our HealthEx series, live from the inaugural McDermott HealthEx conference in Nashville, TN. On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group sits down with Sarah Kitchell, Partner at McDermott Will & Emery, and Michael Zawadski, CEO of Collabrios Health, to explore trends and deal dynamics in the evolving post-acute care landscape. They discuss the resurgence of M&A activity, the impact of value-based care and Medicare Advantage, technology’s growing role, and the importance of scalable, integrated networks.
Kicking off our HealthEx series, Driving the Deal is live from the inaugural McDermott HealthEx conference in Nashville, TN! Brian Fortune, Senior Managing Director at Farragut Square Group and Krist Werling, Partner & Global Head, Health & Life Sciences at McDermott Will & Emery are joined by Farragut’s own Director or Research, Jackie Williams and Colby Catania, Senior Vice President in Houlihan Lokey's Healthcare Group. They dive into current investment trends and market dynamics in the pharmacy and durable medical equipment (DME) sectors, with a spotlight on the booming infusion therapy space. They discuss payer and reimbursement landscapes, regulatory tailwinds, the impact of inflation on DME rates, and why investor interest in healthcare services remains high. Tune in for insights on deal activity, the evolving pharmacy supply chain, and what’s ahead for the rest of the year.
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, sits down with Joel White, President & CEO of Horizon Government Affairs, to unpack the evolving healthcare policy landscape on Capitol Hill. With Congress already in an ambitious legislative year, they explore:
- The top congressional priorities shaping the policy agenda
- How Medicaid reform may play into the broader budget strategy
- What else is on the table—from PBM reform to Medicare fixes
- The outlook for key players like pharma and physicians seeking relief
- The political dynamics at play across the House, Senate, and White House
Joel shares insights on what stakeholders should watch for, what ideas might actually move, and how the healthcare industry is responding.
This episode was recorded before a few key developments in the Medicaid and Medicare space, but the insights remain highly relevant to understanding the broader context and motivations behind current proposals.
In this episode of Driving the Deal, host Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Rodney Whitlock, Vice President at McDermott+ and a longtime Capitol Hill health policy expert. Together, they unpack why Medicaid has become a political flashpoint in 2025. With the concurrent budget resolution passed earlier in April, they explore what’s driving urgency in Congress, the complex dynamics between the House, Senate, and White House. They also break down the policies most likely to advance, including work requirements and targeted savings efforts, and why providers and advocates should be watching the reconciliation process closely as decisions move faster than many expect.
This episode was recorded in April 2025, just before several major Medicaid policy proposals were formally released. While some timelines have moved quickly since then, the conversation offers critical context on the political and policy forces shaping Medicaid reform this year
In this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group and Krist Werling, Partner & Global Head, Health & Life Sciences at McDermott Will & Emery are joined by three very special guests from J.P. Morgan, Matt Wedge, Managing Director & Co-Head of Middle Market Healthcare Investment Banking; Michael Smith, Executive Director; and Trey Hanlan, Managing Director. Together, they discuss signals shaping the healthcare investment landscape, from M&A momentum to sector hot spots, and share what they’re watching as we head into the 2025 J.P. Morgan Healthcare Leadership Summit in Nashville.
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Jackie Williams, Director of Research, and Hope Amsterdam, Lead Post-Acute Care Analyst, to unpack the key takeaways from our recent webinar on the 2025 outlook for Home Health, Hospice, Home Care, HME, and Home Medical Supplies. This episode covers deal volume and valuation trends, regulatory and reimbursement developments, growth and consolidation opportunities, and what’s driving strategy and risk across sectors. From PDGM and Medicaid reforms to labor pressures and due diligence must-knows, this conversation offers a focused view on what investors and operators need to know heading into the year.
In this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, and Krist Werling, Partner & Global Head of Health & Life Sciences at McDermott Will & Emery, are joined by Rebecca Springer, Director of Market Development at Bailey & Company, to break down the biggest takeaways from HPE Miami. They dive into the 2025 deal outlook, key macroeconomic drivers and challenges, lender sentiment, emerging deal strategies, and what recent activity reveals about the health of the market.
Tune in for expert insights on the risks and opportunities shaping healthcare private equity in the year ahead!
The information conveyed during this interview is based on secondary market research, analysis of financial information available to or provided to Bailey & Company, and a range of interviews with industry participants. Bailey & Company has not independently verified the information provided or available to it and makes no representation or warranty, express or implied, regarding the accuracy or completeness of such information. Any projected market and financial information, analyses, or conclusions expressed during this interview are based on the aforementioned information and Bailey & Company’s judgment. These should not be construed as definitive forecasts or guarantees of future performance or results. The information and analysis presented do not constitute advice of any kind and are not intended for investment purposes. Neither Bailey & Company, its subsidiaries, nor their respective officers, directors, or employees accept any responsibility or liability for the use of or reliance on any information or analysis contained in this interview. Securities are offered by and conducted through Bailey & Co. Securities, LLC, an SEC registered broker-dealer and member of FINRA and SIPC. Bailey & Co. Securities, LLC is a wholly owned subsidiary of Bailey & Company Parent, LLC dba Bailey & Company. Testimonials may not be representative of the experience of all clients. Testimonials are not a guarantee of future performance or success.
This special quarterly series of the Governing Health podcast with SullivanCotter highlights developments in and offers support to the board’s executive compensation committee in light of the many complex operational, technical, and strategic issues that the committee confronts.
In this episode, Michael Peregrine, Tim Cotter, Bruce Greenblatt, Kathy Hastings, and Jeff Holdvogt offer recommendations for the committee to focus on in 2025, including:
- Establishing appropriate incentive goals in an evolving health system
- Prioritizing executive succession planning/leadership development
- Keeping appraised of regulatory and market trends
- Ensuring flexibility and defensibility in committee approval processes
- Aligning key governance documents to fulfill committee fiduciary duties
- Evaluating committee reporting and coordination with other board committees
- Overseeing executive compensation in for-profit and not-for-profit ventures subsidiaries
- Considering board compensation trends in not-for-profit health systems
- Determining the need to evolve committee composition
- Addressing executive compensation scrutiny
Additional Resources:
McDermott Will & Emery
We’re delighted to offer the latest episode in the Governing Health: Board Dialogue series, featuring Ken Kaufman, co-founder and managing director of healthcare management consulting firm Kaufman Hall. In this episode, Ken and podcast host Michael Peregrine examine some of the most bewildering challenges facing hospital administration in recent years. Against this backdrop of rapid change, a well-informed and prepared board is more critical now than ever before.
Ken shares his insight on:
- Tackling current hospital operation complexities
- Issues that relentlessly plague hospital operations
- The role of outpatient services in financially successful hospitals
- Managing the competitive landscape on the outskirts of hospital services
- Addressing the long-term issues for governing boards
- Board preparation for significant cuts to Medicaid
- Interfacing with consumers in revenue-increasing ways
Additional Resources:
McDermott Will & Emery
The first episode of the new season of Driving the Deal is here! In this episode, Brian Fortune, Senior Managing Director at Farragut Square Group is joined by Carlos Orantes, CEO of Alcanza Clinical Research, and Erik Kistler, Managing Director of Houlihan Lokey’s Healthcare Group, to dive deep into the world of clinical research sites and their growing appeal in the private equity space. They’ll be providing an overview of the clinical research site landscape, covering topics such as:
- Insights into why private equity has targeted this sector, including key financial trends and investment benchmarks.
- What investors need to know before entering the market, from evaluating business models to navigating industry-specific risks.
- A look at the major players and the critical regulatory factors that influence valuations, capital allocation, and exit strategies.
- Proven strategies for successful investments in clinical research sites and predictions for the sector’s future dynamics.
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, sits down with Vikram Sithian, Managing Director and Head of Healthcare Financial Sponsors Coverage at Cantor Fitzgerald, to explore the key trends shaping the healthcare private equity landscape. They discuss the latest in healthcare services dealmaking, delve into subsector activity among sponsors, and highlight the most active areas and emerging themes. The conversation also touches on varying sponsor strategies, the new players entering the healthcare space, and the current state of the financing market.
On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Trey Marinello, Managing Director for Houlihan Lokey’s Healthcare Group, and Chad Schulz, Executive Vice President and Managing Director at Alliant Insurance Services. Live from the Houlihan Lokey Global Healthcare Conference in New York City, they embark on a riveting conversation on the booming private equity interest in employer-sponsored healthcare (ESHC). They discuss the macro drivers attracting investors, key attributes of ESHC companies, and strategies for standing out in a crowded market. The conversation covers go-to-market approaches, including the role of insurance brokers, client segmentation, and growth tactics. Trey and Chad also explore value-creation strategies, tackling vendor fatigue, improving revenue quality, and leveraging M&A to maximize portfolio company potential.
On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Mark Francis, Managing Director and Global Head of the Healthcare Group at Houlihan Lokey. They discuss the state of healthcare private equity in 2024. Mark shares insights on deal activity, key market impacts, emerging opportunities, and the influence of digital healthcare. He also highlights the big challenges and trends shaping the industry. Finally, we wrap up with Mark’s thoughts on what to expect for the rest of the year.
In this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by his colleague, Sharon Lamb, Partner and head of the U.K. Healthcare Practice Group at McDermott Will & Emery. Together, they debrief the HPE Europe 2024 conference in London, covering key trends, including selective deal activity, biotech and pharma services growth, and the rise of medtech driven by AI. Sharon also highlights the challenges of navigating exits and the regulatory landscape in medtech, as well as the outlook for bioscience deals over the next two years.
On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by David Schuppan, Senior Partner and Co-Head of Healthcare at The Vistria Group, for the very first episode of our Fund Founders series. They set off on an insightful discussion on healthcare trends, investments, and innovation. David shares his perspective on the themes that have driven his career, the businesses he's proud of, and subsectors that have transformed the industry. Tune in as we explore where healthcare is headed, highlighting areas primed for future disruption and meaningful change.
On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Eugene Goldenberg, Managing Director at Edgemont Partners. Together, they explore the dynamic post-acute care sector and the latest trends in healthcare M&A. Eugene offers a deep dive into the current state of the market, highlighting key trends in personal care, hospice, and home health. Brian and Eugene discuss what’s driving M&A activity, explore valuation trends, and uncover the challenges and opportunities investors face in this space. The conversation also touches on the broader healthcare M&A landscape, including the impact of regulatory changes. Finally, Eugene shares his insights and predictions for the future of post-acute care.
On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by his colleague, Paul Hughes, co-head of the McDermott Will & Emery’s practices focusing on Supreme Court & Appellate Litigation as well as Government & Regulatory Litigation. Together, they explore the recent Loper Bright decision that ended Chevron deference. Paul breaks down the ruling, discusses its implications in the healthcare space, and considers how it might impact existing regulations. Key areas of focus include potential changes for healthcare providers, the effect on private equity investments, and what stakeholders should prepare for in this new legal landscape. Tune in to understand how this ruling could reshape healthcare and investment strategies.
Today’s podcast examines whether board compensation, if appropriate, is legally feasible and whether healthcare organizations need to implement such programs in order to recruit, retain, and recognize board members. Host Michael Peregrine is joined by guest Bruce Greenblatt, Managing Director at Sullivan Carter. Together they cover a range of considerations for not-for-profit healthcare organizations on the adoption and design of a board compensation program.
Bruce believes that the board compensation programs are both beneficial and necessary, and during the conversation, he shares insights on:
- Why these programs are experiencing a resurgence in examination and implementation
- The single greatest factor prompting this discussion
- Common themes of incorporating this rationale with a strong fact-base
- Key options for boards at the onset of the design process
- Compensation options that have proved effective
- Establishing the reasonableness of a board compensation package
- Addressing organizational reluctance to adopt director compensation programs
Additional Resources:
McDermott Will & Emery
On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Baxter Lee, CFO of Clearwater Security, to discuss the escalating issue of cybersecurity in the healthcare sector. Baxter sheds light on recent cyber-attacks, including the Change Healthcare breach, and examines their financial, operational, and privacy impacts. He explains how Clearwater collaborates with healthcare organizations to enhance their cybersecurity posture and offers insights into the future of healthcare security. Baxter also shares best practices for defending against cyber-attacks, emphasizing strategic financial planning, compliance, and regular assessments. Tune in for a riveting discussion on safeguarding healthcare against cyber threats.
On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Farragut’s own Assistant Vice President, Holly Stokes. Holly breaks down the newly released Physician Fee Schedule (PFS) rule for 2025, discussing the PFS mechanics, key proposals, and anticipated pressures. They review the net cut to the conversion factor and its impact on stakeholders, including potential Congressional interventions and pandemic telehealth flexibilities. Additionally, the conversation highlights bright spots in primary care, gastroenterology, and behavioral health.
On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group is joined by Farragut’s own Assistant Vice President, Holly Stokes, and Sheila Madhani, President of Madhani Healthcare Consulting, as they dive into predictions for the upcoming 2025 Physician Fee Schedule Rule. They share their insights into the rule’s potential impact, as well as providing an update on congressional relief, and what this could mean for the conversion factor in 2025. This episode was recorded prior to the official release of the Physician Fee Schedule Rule, and predictions and analyses are based on preliminary information and may be subject to change following the rule's publication.
On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, and Krist Werling, McDermott Partner and co-head of the Firm’s Private Equity Practice Group, are joined by L.A. Galyon IV, Managing Partner at Brentwood Capital Advisors discussing the evolving healthcare deal market, key drivers, challenges, and notable trends shaped by technological advancements. We'll also delve into Brentwood's unique strategies, recent milestones, and what sets them apart in this dynamic landscape.
On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, and Krist Werling, McDermott Partner and co-head of the Firm’s Private Equity Practice Group, are joined by their colleague, Jiayan Chen, also Partner at McDermott Will & Emery. Together, they provide an overview of the pharma services space and, specifically, dive into clinical trial site management, a space that Krist and Jiayan have worked in extensively over the years. They share insights in investing in the space and discuss key players and key regulatory considerations.
In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by Farragut’s own Assistant Vice President, Holly Stokes. Holly provides an update and 2024 outlook for the No Surprises Act (NSA). They discuss the carve out, as well as the status of the committee and their recommendations. Along with this update, they share their thoughts on the NSA’s potential impact on the industry.
The Driving the Deal podcast is back for its fourth season! We're bringing you the latest topics impacting the healthcare private equity space. In this new episode, Brian Fortune, Senior Managing Director at Farragut Square Group, and Krist Werling, McDermott Partner and co-head of the Firm’s Private Equity Practice Group, are joined by Farragut Square Group’s Assistant Vice President, Holly Stokes, and Director of Research, Jackie Williams, to provide insights from the 2024 J.P. Morgan Healthcare Conference in San Francisco. Together, they discuss what people are expecting this year in the deal market, providing key takeaways and sharing their thoughts on various sector themes.
In this special episode of a multi-part series, host Brian Fortune, senior managing director at Farragut Square Group, is joined by his colleague, Devin Stone, head of data analytics at McDermott+ Consulting (M+) and former economist at Centers for Medicare and Medicaid Services Office of the Actuary, where he served as co-lead for the 2016-2025 national health expenditure projections. They embark on the first ever videocast edition of Driving the Deal, which can be found on Farragut’s YouTube page (link below). Together, they highlight interesting trends and offer their own thoughts on CMS’s national health expenditures projections for 2022 through 2031, current healthcare spending, national health insurance coverage, and Medicare Fee-for-Service & Medicare Advantage enrollment.
Youtube Link: https://youtu.be/c0QTaaOf9c4?si=39XQDR3XPZ_m843e
In this episode, host Brian Fortune, senior managing director at Farragut Square Group, and Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, sit down with John Jamison, Director of Healthcare Investment Banking at Cantor Fitzgerald. Together, they discuss the macroenvironment of the allergy and ENT space, commenting on what’s sparking interest in the sector and what’s in store for the next year. Additionally, they take a look at the service mix and provide thoughts on investing in the space.
We’re delighted to offer the latest episode in our popular series of podcast dialogues with Ken Kaufman, co-founder and managing director of healthcare management consulting firm Kaufman Hall.
In this episode, Ken and host Michael Peregrine return to the social science concept of “wicked problems”—problems that have no single, correct solution. In fact, a solution that improves one aspect of a wicked problem usually makes another aspect of the problem worse.
Ken believes that the current hospital operating environment is overwhelmed by wicked problems. During the conversation, he shares his insight on:
- How wicked problems impact hospital-client issues
- Keeping management and boards appropriately informed and engaged, including key metrics that board members must be aware of
- Balancing the crisis of regulation with a hospital’s need to scale
- Addressing and debriefing the board on post-COVID-19 strategies
- Managing media and political attacks on hospitals
Additional Resources:
McDermott Will & Emery
In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by his colleague, Sharon Lamb, Partner and head of the U.K. health practice at McDermott Will & Emery. Together, they debrief HPE Europe 2023, discussing their findings on investment trends and opportunities, as well as current market challenges. They also provide insight on innovative advancements, market dynamics, and forecasts for 2024.
In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by Houlihan Lokey’s own Mark Francis, Managing Director and Global Head of its Healthcare Group. Together, they discuss the sectors expected to see an increase in deal volume and activity, a review of activity and deal flow in the last three quarters, sectors that are cooling off, the impact of digital health in the healthcare industry, and an outlook for the rest of the year and 2024.
In this episode, host Brian Fortune, senior managing director at Farragut Square Group (FSG), is joined by FSG’s own Assistant Vice President, Holly Stokes, in an insightful overview of the recently released 2024 Physician Fee Schedule (PFS) proposed rule. They shed light on the PFS’s significance and impact on providers. Holly provides a comprehensive overview of the proposed changes, including the notable 3.4% cut to the conversion factor, and presents an outlook for potential congressional intervention as well as other specialty-specific changes.
In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by L.A. Galyon IV, managing partner at Brentwood Capital Advisors, for the final segment of our three-part behavioral health series. Together, they have a riveting conversation on the psychiatry space, discussing today’s macro-environment and service mix. Additionally, they provide insights on current reimbursement issues and investment opportunities within the sector.
During this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by L.A. Galyon IV, managing partner at Brentwood Capital Advisors, for part two in our three-part behavioral health series. Together, they delve into the substance use disorder (SUD) space and its macro environment. They also share their thoughts on the evolving demand for relevant services in recent years and provide valuable insights on investment opportunities within the SUD sector.
In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by Dan Beuerlein, managing director at Brentwood Capital Advisors. Embarking on a three-part behavioral health series, Brian and Dan discuss the autism space, including the macro environment for autism, as well as the service mix and evolution. They also share their thoughts on investing in the autism space.
In this episode, hosts Kristian Werling, McDermott partner and co-head of the Firm’s Private Equity Practice Group and Brian Fortune, senior managing director at Farragut Square Group, recap McDermott’s 2023 HPE Miami event. Together, they share key themes from the conference, discuss current healthcare deal market highlights and chat about various areas of interest and activity in spaces such as infusion/AICs, cardiology, ophthalmology, home care personal services, payor services, etc. Brian and Krist also share their thoughts on the timing of market activity and Silicon Valley Bank’s impact on the market.
In this episode, host Brian Fortune, senior managing director at Farragut Square Group, and Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, are joined by Brown Gibbons Lang & Company’s own John M. Tiedmann Jr., Director and senior member, and J. Kyle Brown, Managing Director and senior member of their Healthcare & Life Sciences team. They discuss the current state of the deal market and deal flow and provide insight into the most active spaces in healthcare and the macro market forces affecting opportunities this year.
In this episode, host Brian Fortune, senior managing director at Farragut Square Group, conducts an intimate interview with PT Solutions Chief Strategy Officer (and former Private Equity Sponsor) Matt Beck-Goolsby. Together, they provide an overview of the PT market and discuss:
· How PE-backed PT assets can add value to hospitals
· The labor market and supply and demand imbalance within PT
· Lessons learned from failed PT deals
· Tech-enabled advantages
· Future opportunities within the PT market
The Driving the Deal podcast is back for a third season, bringing you the latest topics impacting the healthcare private equity space. In this new episode, Brian Fortune, Senior Managing Director at Farragut Square Group (FSG), and Krist Werling, McDermott Partner and co-head of the Firm’s Private Equity Practice Group, are joined by Farragut Square Group Assistant Vice President Holly Stokes to provide insights from the 2023 JPM Healthcare Conference and an overview of what to expect this year in the deal market. They discuss key takeaways on the state of the M&A market and touch on various sector themes.
In Season 2, Episode 15 of Driving the Deal, host Brian Fortune, senior managing director at Farragut Square Group (FSG), is joined by FSG’s Health Policy Senior Associate Holly Stokes and Assistant Vice President Hope Amsterdam. Together, they provide an overview of the 2022 midterm election results and discuss which legislative issues we can expect taken up in 2023.
During this episode, they talk about:
- Upcoming end-of-year legislation
- Midterm implications for the Inflation Reduction Act of 2022 and drug pricing
- Future telehealth and behavioral health legislation
- The split US Congress and how it will affect past and future legislation
- The impact election results will have on the fertility space post Dobbs
In the 14th episode of Season 2: Driving the Deal, Krist Werling, McDermott Will & Emery partner and co-head of the Firm’s private equity practice, and Brian Fortune, senior managing director at Farragut Square Group, recap McDermott’s 2022 HPE New York event. Together, they share key themes from the conference and discuss current healthcare deal market highlights, including:
- The trends slowing down large deals while also powering activity in the low and middle market
- The current debt market, outlook for 2023 and potential financing opportunities
- A look at the activity within the pharmaceutical services space
- An overview of recent CMS rulemaking (e., PFS, OPPS, home health and ESRD)
- The future of dealmaking as we head toward a potential recession
In Season 2, Episode 13 of Driving the Deal, Farragut Square Group’s (FSG) Brian Fortune and Jackie Williams are joined by FSG’s Assistant Vice President Hope Amsterdam. In this episode, they discuss recent reimbursement-related developments for Medicare and Medicaid on the state level, as well as:
- Major Medicare and Medicaid investments made by states during the most recent budget cycle
- Positive July rulemaking for post-acute care and inpatient psychology
- Reimbursement adjustments for hospice, inpatient rehabilitation facilities and inpatient psychology
- Case-mix adjustments to the positive skilled nursing facility (SNF) patient-driven payment model
- Centers for Medicare & Medicaid Services’ (CMS) final rule for SNFs
- Home Health proposed "Temporary” and “Permanent” adjustments
In the 12th episode of Season 2: Driving the Deal, Farragut Square Group’s (FSG) Brian Fortune and Jackie Williams are joined by Holly Stokes, senior research associate at FSG, for a discussion on the future of physician practice management (PPM). Specifically, the trio delves into the regulatory actions that occurred within the PPM sector this past year as we head into end-of-year legislation and rulemaking, as well as the anticipated pressures for market participants in 2023 and 2024. In this episode, they also talk about:
- Regulatory changes for PPM companies
- Proposed cuts to the Physician Fee Schedule
- Implications of the ruling in Dobbs v. Jackson Women’s Health Organization on the fertility and OBGYN sectors
- Drug pricing provisions in the Inflation Reduction Act of 2022
- Future implementation of the No Surprises Act and qualifying payment amount calculation
In the 11th episode of Season 2: Driving the Deal, Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined for a guest interview hosted by Farragut Square Group’s own Jackie Williams and Hope Amsterdam. In this episode, Hope and Jackie interview Damon Terzaghi, senior director of LTSS policy at the National Association of States United for Aging and Disabilities, to provide an overview of the home- and community-based services (HCBS) space. Together, they discuss the following:
- The increase in demand for HCBS before and after COVID-19
- The increased Federal Medical Association Percentages reimbursement for HCBS
- The likelihood of increased funding to exist beyond the public health emergency
- Labor issues surrounding the HCBS space
- Priorities for states surrounding HCBS after the pandemic
In the 10th episode of Season 2: Driving the Deal, Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined by Mark Francis, managing director at Houlihan Lokey and head of its Healthcare Group, as they summarize the end of Q2 for the healthcare industry. Together, they discuss the following:
- Healthcare sectors poised to see an increase in deal volume and activity
- A review of activity and deal flow in Q1 and Q2
- Sectors that are cooling off post-Q1 and Q2
- The impact of digital health on the healthcare industry
- Sectors heading into distress territory
- Q3 insights
In the newest episode of Season 2: Driving the Deal, Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined by Ashley Fischer, McDermott health antitrust partner. Together, they discuss the following concerning healthcare antitrust in the Biden administration:
- The Federal Trade Commission’s (FTC) signaled interest in the effect of private equity on competition
- How the FTC views hospital consolidation
- Major cases in the physician market and subsequent enforcement activity
- Tips for investing with new scrutiny
- Labor market competition and recent significant cases
In episode 8 of Season 2: Driving the Deal, Brian Fortune, senior managing director at Farragut Square Group (FSG), is joined by Elle Kalisz, a research analyst at FSG, and Swatee Survee, CEO and founder of Litesprite. Together, they explore all things digital technology, including:
- What is a Digital Therapeutic?
- What makes a Digital Therapeutic different from traditional digital health tools?
- The intersection of digital self-help tools and mobile gaming.
- Provider, payor and employer uptake/participation.
- Insights for investors interested in the digital technology space.
In Season 2, Episode 7 of Driving the Deal, Krist Werling, McDermott partner and co-head of the Firm’s Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined by Brian Stimson, a partner in McDermott’s Healthcare Practice Group and former Acting General Counsel and Principal Deputy General Counsel for the US Department of Health and Human Services. Together they discuss current litigation surrounding the impending future of the No Surprises Act, as well as:
-The specialties most impacted by the legislation and subsequent litigation
- An overview of the No Surprises Act and current litigation surrounding it
-The Act’s impact on providers
-Next steps for future litigation
In the sixth episode of Season 2: Driving the Deal, Krist Werling, McDermott Partner and Co-Head of Private Equity and Brian Fortune, Senior Managing Director at Farragut Square Group, are joined by Brian Stimson, Healthcare Partner at McDermott Will and Emery and former Acting General Counsel & Principal Deputy General Counsel for US Department of Health and Human Services, discuss the unwinding of the COVID-19 Public Health Emergency (PHE). They discuss the following topics:
- Expected end of the COVID-19 PHE
- Conclusion and future of telehealth flexibilities
- Medicaid eligibility issues associated with the end of the PHE
- Remaining PREP Act Declarations
- Next moves for CMS and other agencies
In the fifth episode of Season 2: Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, and guest co-host Holly Stokes, Senior Associate at Farragut Square Group, are joined by Justin Santa Cruz, Chief Development Officer at US Eye, an integrated, multi-specialty eye care platform. Recording live at McDermott’s annual Physician Practice Management & ASC Symposium in Nashville, Brian, Holly and Justin discussed:
- Operational and demand changes US Eye made in response to COVID-19
- Current challenges and opportunities in the ophthalmology space
- Key features of ophthalmology assets for acquisitions and expansion
- The increasing role of private equity in ophthalmology
- The outlook for M&A activity in ophthalmology for 2022
In the fourth episode of Season 2: Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, and guest co-host Jackie Williams, Head of Research at Farragut Square Group, are joined by Holly Stokes, Senior Associate at Farragut Square Group, live at McDermott’s annual Physician Practice Management & ASC Symposium in Nashville. Brian, Jackie and Holly discuss:
- The stability and continued interest in gastroenterology and ophthalmology
- Specialties emerging as the next frontier for PPMs
- Challenges and special considerations for cardiology and ambulatory infusion
- The current macro pressures for PPMs including budget neutrality, clinical labor, sequester and pay-go
In the third episode of Season 2: Driving the Deal, Krist Werling, McDermott Partner and Co-Head of Private Equity, and Brian Fortune, Senior Managing Director at Farragut Square Group, are joined by Mark Francis, Head of Healthcare and Managing Director at Houlihan Lokey, live at McDermott’s annual Health Private Equity event in Miami. They discuss the following topics: * Healthcare sectors poised to see an increase in deal volume and activity * Convergence of sectors creating new services in the next five years * Future of orthopedic deals and changing sector activity * “Transformative” deals and entering the innovative side of healthcare * Value-based care and its impact on the market
On this episode of In the Trenches, McDermott partner and program host Brian Stimson continues his conversation with Mark Farrar and Katherine Norris of Epsilon Consulting and Mara McDermott, Vice President of McDermott+Consulting to discuss their thoughts on the Cares Act and Provider Relief Funds, including:
- Pain points for providers on PRF compliance and enforcement
- Proactive steps to mitigate PRF fund risk regarding balance billing
- A simple and conservative approach to the loss of revenue methodology
- Risks and considerations presented with “double-dipping”
- Best practices for providers to mitigate risk in 2022
- Points when engaging with HRSA
Additional Resources:
McDermott Will & Emery
On this episode of In the Trenches, McDermott partner and program host Brian Stimson sits down with J. Mark Farrar and Katherine Norris of Epsilon Life Sciences and Mara McDermott, Vice President of McDermott+Consulting to review the history of the PRF, the big pain points for PRF recipients, and what to do about them, including:
- How HHS stood up the PRF at the height of the pandemic
- How different PRF recipients operationalized the program requirements
- What providers can still do if HHS denied some or all the PRF funds they sought
- How the recent history informs current PRF reporting and enforcement risks
- The biggest reporting and compliance pain points for PRF recipients
- What PRF recipients should expect, and do next
Additional Resources:
McDermott Will & Emery
In this second episode of Season 2 of Driving the Deal, Krist Werling, McDermott Partner and Co-Head of Private Equity, and Brian Fortune, Senior Managing Director at Farragut Square Group, are joined by Frank Martin, Head of Commercial Care at Farragut Square Group and a leader in commercial managed care. The topics discussed include: - The dominant trends in the commercial care market heading into 2022
-
The state of beneficiary enrollment in Medicare Advantage
-
Managed care payor interaction in the Behavioral Health space and Medicaid
-
Proactive revisions to change of control specifications in deal contracts
In this episode of Driving the Deal, Krist Werling, McDermott Partner and Co-Head of Private Equity, and Brian Fortune, Senior Managing Director at Farragut Square Group, are joined by Holly Stokes, Senior Analyst at Farragut Square Group and veteran of numerous healthcare deals across the provider continuum. The topics they discuss include: * The state of the deal market in 2022 * Deal questions surrounding PPMs * Overview changes impacting the post-acute and home health sectors * Changing activity in the behavioral sectors with a focus on SUDS * Increased deal activity in the digital health space
On this episode of In the Trenches, McDermott partner and program host Brian Stimson sits down with Michael Kimberly, co-chair of McDermott’s Supreme Court appellate practice, and Bill Dombi, President of the National Association for Homecare and Hospice, to discuss their thoughts on the relationship between litigation and healthcare policy, including:
- Insights from Michael's and Bill’s careers on the APA litigation side of health law
- How to engage with agencies to increase the likelihood of obtaining good policy outcomes without resorting to litigation
- Similarities between the rulemaking process and trial court proceedings and the importance of appellate strategy to both
- Engagement with the Hill to help drive the outcome of the rulemaking process
- The challenges of litigation and parallel rulemaking
- Key cases to follow in 2022
Additional Resources:
McDermott Will & Emery
Lyn Amor Macaraeg is the Vice President of Legal Services and Corporate Secretary with agilon health, and is a longtime colleague and friend of program host Brian Stimson. Lyn began her career at the California Department of Managed Health Care (DMHC), and has over 15 years of legal experience, including serving as in-house counsel to leading health plans. On this episode of In the Trenches, McDermott partner and program host Brian Stimson sits down with Lyn to discuss:
- Insights from Lyn’s move into the managed care side of health law, from her time with the DMHC to her role as VP of Legal Services for agilon health
- agilon health’s unique platform and physician partnership model, and differs from traditional physician practice management
- How to overcome the challenges of supporting and expanding independent physician practices
- Key differences between the new direct contracting model and a traditional Medicare accountable care organization
- The impact of agilon’s model on physician workflow and patient care, and the significant benefit of value-based care
Additional Resources:
McDermott Will & Emery
McDermott+Consulting Vice President Rodney Whitlock has nearly 25 years of experience in the health policy arena, having spent more than two decades as a staff member on Capitol Hill before moving into health policy consulting. On this episode of In the Trenches, McDermott partner and program host Brian Stimson sits down with Rodney to discuss:
- Insights from Rodney’s time on Capitol Hill, from the Republican takeover of Congress in 1994 to the Obama administration in the 2010s
- Lessons learned from the successes and failures of both parties on big health policy matters
- The value of listening, political shifts in the US and the state of health policymaking in Congress today
- Key health policy priorities for the current administration and Congress
- Insights into reconciliation efforts and critical policy changes with telehealth and Medicare
Additional Resources:
McDermott Will & Emery
McDermott+Consulting Vice President Debbie Curtis served as a chief of staff to a member of Congress and a member of the professional staff on the House Committee on Ways & Means, as well as a deputy director of the DC Health Benefit Exchange. On this episode of In the Trenches, McDermott partner and program host Brian Stimson sits down with Debbie to discuss:
- Debbie’s experience with health policy on Capitol Hill
- Lessons learned from growing the DC Health Exchange
- Debbie’s perspective on the Administration’s prioritization of health equity and approaches to Medicare and Medicaid.
- Insights into the potential post-pandemic public healthcare priorities of the Administration and the Congress, including hospital structures and telehealth
- Key issues for today’s public health system
Additional Resources:
McDermott Will & Emery
As the United States Attorney for the District of Hawaii, McDermott partner Kenji Price led a team responsible for representing the United States in a wide array of criminal and civil litigation. On this episode of In the Trenches, he sits down with host Brian Stimson to discuss:
- His military experience and the impact it had on his approach to leadership
- The importance of relationship building with the law enforcement community
- Leading the US Attorney’s Office in Hawaii, including his work on national security and drug trafficking matters
- Insights for general counsels on heightened enforcement activity from COVID-19, including government fraud and cybersecurity
- The impact of corporate culture on compliance, responding to investigations and federal enforcement
Additional Resources:
McDermott Will & Emery
The President’s recently-released budget presents policy and business questions for every industry within the health sector. To help make sense of the potential impact on the health sector, today’s episode of In the Trenches zeroes in on the proposals in the budget related to the Department of Health and Human Services (HHS).
Jen Moughalian, former Acting Assistant Secretary for Financial Resources at HHS and Mara McDermott, Vice President of McDermott+Consulting, join host Brian Stimson to discuss:
- Presidential budget proposals and federal budgeting during transitions generally
- HHS programs that may benefit from the proposed spending increase in the budget
- Business opportunities and timelines related to the Advanced Research Projects Agency for Health (ARPA-H) accelerator initiative at the National Institute of Health
- Biden campaign promises reflected in the budget, including cancer research and civil rights issues
- Potential impact of equity policies on government grants and contracts
- Treatment of Medicare, Medicare Advantage, Medicaid, and Exchange plans in the budget
- Jen and Mara’s insights into probable year-end actions and impending bills
Additional Resources:
McDermott Will & Emery
McDermott+Consulting
Conversation with a "Lawyer's Lawyer" on Appellate and Executive Branch Advocacy
Jenn Dickey, Associate Chief Counsel at the US Chamber Litigation Center for the US Chamber of Commerce, is the quintessential lawyer’s lawyer, having served as a Supreme Court Clerk, Associate Counsel to the President, and Deputy Associate Attorney General. On this episode of In the Trenches, Brian Stimson, McDermott partner and former Acting General Counsel and Principal Deputy General Counsel for the US Department of Health and Human Services (HHS), sits down with Jenn to discuss her perspectives on:
- Supreme Court and appellate advocacy
- The roles of White House Counsel’s Office, the US Department of Justice and federal agencies in rulemakings and administrative litigation
- The DOJ litigating components and their roles, institutional interests and approaches to litigation
- Key issues in Administrative Procedure Act litigation for American businesses
- Hot class action and mass action issues, including no-injury class actions, predominance and mass arbitrations
McDermott partner Julian André served as a federal criminal fraud prosecutor for six years in one of the busiest and most dynamic jurisdictions in the United States: the Central District of California. His service spanned the COVID-19 pandemic when the U.S. Department of Justice was ramping up efforts to police frauds on COVID-19 relief programs. On this episode of In the Trenches, Brian Stimson, McDermott partner and former Acting General Counsel and Principal Deputy General Counsel for the US Department of Health and Human Services (HHS), explores the following topics with Julian:
Increased enforcement activity and fraud prosecution following the implementation of COVID-19-related government programs
Julian’s experience in the Central District, including his leadership and work on securities and education fraud enforcement
Julian’s perspectives on healthcare fraud enforcement in the Central District of California and other jurisdictions
Insights and words of wisdom for general counsels navigating investigations or litigations in the Central District
Driving the Deal Podcast: Restructuring and Bankruptcy Considerations
2020 brought a global liquidity crunch impacting many industries, including healthcare. In this episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling speaks with colleague Felicia Perlman, Partner and Global Co-Head of McDermott’s Restructuring and Insolvency Practice Group. They discuss restructuring and bankruptcy trends, including the impacts to private equity and forecasts for the healthcare industry moving forward. Specific topics include:
-
Restructuring trends that are unique to the healthcare industry
-
Strategic guidance for private equity investors when preparing for a potential restructuring
-
Industries prime for restructuring and their impact on healthcare
Additional Resources:
McDermott Will & Emery
Collaborative Transformation
Healthcare Life Sciences News Blog
HPE Miami 2021
A revitalized focus on antitrust in healthcare has increased healthcare companies’ concerns about their compliance status. On this episode of In the Trenches, Brian Stimson, McDermott partner and former Principal Deputy Counsel for the US Department of Health and Human Services, and Antitrust partner Justin Murphy, former prosecutor in the Department of Justice Antitrust Division, for an overview of healthcare antitrust enforcement issues and proactive steps companies need to take in order to remain compliant. Brian and Justin discuss:
- The focus of DOJ’s Procurement Collusion Strike Force (PCSF) and defining the “red flags of collusion”
- DOJ’s use of data analytics
- The top two industries facing increased antitrust enforcement attention, cases to watch and practical steps for companies under investigation
- The role of a computer hacking and intellectual property (CHIP) prosecutor
- The value of experienced defense counsel in antitrust investigations
- Recommended steps for healthcare organizations to assess their procurement protocols and other compliance programs
Additional Resources:
McDermott Will & Emery
Driving the Deal Podcast: The Evolving Role of Insurance in Private Equity Investments
In this episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling is joined by Neil Krauter, National Practice Leader of Private Equity at Risk Strategies and Founder of Krauter & Company. With a wealth of experience in private equity insurance, Neil explains how private equity funds' needs have changed and addresses current trends in the space, including:
- The evolving role of rep and warranty insurance in private equity investments
- Insurance dynamics and issues in the rapidly changing SPAC deal space
- Key insights into due diligence, billing and coding
Additional Resources:
McDermott Will & Emery
Harris Williams
Collaborative Transformation
Healthcare Life Sciences News Blog
HPE Miami 2021
On this episode of In the Trenches, Brian Stimson, McDermott partner and former Acting General Counsel and Principal Deputy General Counsel for the US Department of Health and Human Services (HHS), is joined by Mara McDermott, Vice President of McDermott+Consulting and guest Satya Thallam, former Senior Counselor in the Office of Management and Budget (OMB) for a conversation on rulemaking processes, the Biden administration's expected approach on health policy and more.
Satya, Brian and Mara discuss: * The roles of OMB, the Office of Information and Regulatory Affairs (OIRA) and the Department of Health and Human Services (HHS) in the rulemaking process * Approaches and top tips for effectively engaging with OIRA and OMB * Real-world examples of navigating interagency communication during the rulemaking process * The Biden administration's approach to executive orders in early days of his presidency
On this episode of In the Trenches, Brian Stimson, McDermott partner and former Acting General Counsel and Principal Deputy General Counsel for the US Department of Health and Human Services (HHS), sits down with McDermott partners Ben Curtis and Carlos Ortiz, two former Department of Justice (DOJ) prosecutors with decades of combined experience trying cases and conducting investigations across the US and in collaboration with international enforcement agencies.
Brian, Ben and Carlos look back on the valuable experience they gained and top achievements while with the federal government and look ahead at potential enforcement challenges and proactive steps companies should take when engaging with DOJ, including:
- Company and individual actions that can raise enforcement risks
- Insights into collaborations between civil and criminal prosecutors
- Understanding settlements with DOJ, the UK Serious Fraud Office (SFO) and other international law departments
- Foreign Corrupt Practices Act (FCPA) risk areas facing pharma companies
- Addressing company and country cultures when establishing compliance protocols to mitigate enforcement risk
- Telehealth fraud and other high priority areas of enforcement for the DOJ today
In this episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling speaks with Barry Freeman, Managing Director and Co-Head of Healthcare at Lincoln International, about current trends and topics surrounding the evolution of healthcare and its impact on private equity. They discuss:
-
A shifting mindset surrounding deals in the payor market
-
Key questions private equity investors want answered before investing in healthcare
-
Growth trends in government payor plans and their impact on providers
-
Investor insights into the home healthcare and telehealth spaces
Additional Resources:
McDermott Will & Emery
Harris Williams
Collaborative Transformation
Healthcare Life Sciences News Blog
HPE Miami 2021
In this episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling is joined by Cheairs Porter and Geoff Smith, Managing Directors at Harris Williams, to discuss key topics surrounding mergers and valuations in the private equity space, including:
- Key characteristics of various competitive fund managers and non-traditional private equity funds
- Merging and scaling practice management assets and upcoming platform combination opportunities
- Steps to running a successful auction process from a seller’s perspective
- Valuation predictions for strong healthcare businesses in 2021
Additional Resources:
McDermott Will & Emery
Harris Williams
Collaborative Transformation
Healthcare Life Sciences News Blog
HPE Miami 2021
In the latest episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling is joined by Jeff Woods, Co-Head of Healthcare at EY-Parthenon, to discuss macro trends that are impacting private equity investments in healthcare including:
- The impact of deferred healthcare spending on new private equity deal activity
- Investment opportunities in urgent care, healthcare IT, and surgical specialties
- Key considerations when investing capital in hospitals
- Trending investment activity in healthcare and technology
Additional Resources:
McDermott Will & Emery
EY-Parthenon
Collaborative Transformation
Healthcare Life Sciences News Blog
HPE Miami 2021
Driving the Deal Podcast: A Lender’s Perspective on Healthcare PE Deals
In the latest episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling is joined by Tricia Lebo, Managing Director at Citizens Bank, to discuss opportunities that could spur private equity deals in healthcare. The topics they cover include:
- The current state of the debt markets and their impact on PE deal activity
- Investing opportunities arising from the growth in home medical equipment
- Other healthcare subsectors that are seeing deal activity pick up
Additional Resources:
McDermott Will & Emery
Citizens Bank
Collaborative Transformation
Healthcare Life Sciences News Blog
HPE Miami 2021
In the third and final episode of our series on public hospital M&A, we discuss key regulatory considerations when executing public hospital M&A and planning for post-transaction success. McDermott partners Emily Cook and Megan Rooney are joined by Rex Burgdorfer, managing director at Juniper Advisory to discuss:
- Key regulatory approvals that hospitals must anticipate and address
- Public and government hospital considerations regarding successful 340B participation, including DSH percentage thresholds
- The significance of critical access hospital status to acquirers and steps hospitals can take to maintain this designation and receive the same benefits as larger systems
- Steps hospitals can take to drive quality and financial agreements and promote post-transaction success
- The importance of effectively communicating with employees prior to dealmaking and during the transition period
Catch Up on Past Episodes in This Series
“Driving the Deal: Public Hospital M & A and Stakeholder Buy-in”
“Dealmaking in the Sunlight: Navigating Public Hospital M&A”
Healthcare payors face many potential changes in the coming year, all of which will impact private equity firms’ outlook on the sector. From federal initiatives to growth in value-based care, 2021 promises to bring significant challenges and opportunities for private equity investors in healthcare.
In the second episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling is joined by Frank Martin, Vice President of the Managed Care division at Farragut Square Group. They discuss why payor changes impact private equity, covering:
- What healthcare private equity investors can expect from the Biden administration for future expansion of Affordable Care Act plans
- How payors will likely approach value-based care in 2021 and what that may mean for healthcare PE
- The potential for telehealth to create major disruptions with payors in the provider market and implications for healthcare impact private equity investors
- Opportunities and challenges for healthcare private equity investors in light of potential changes to the production of critical medical equipment and Medicare drug prices
Additional Resources:
McDermott Will & Emery
Farragut Square Group
Collaborative Transformation
Healthcare Life Sciences News Blog
Despite the pandemic's impact, the volume of healthcare private equity transactions accelerated in the latter half of 2020. Now in a new year with a new administration, investors should expect both new opportunities and challenges to emerge in the healthcare sector.
To help navigate the evolving landscape, we're dedicating a series of podcast episodes to healthcare private equity. Hosted by McDermott Partner Krist Werling, look for new episodes as part of the Collaborative Transformation: Driving the Deal feed.
In this first installment, Krist talks with Brian Fortune, Senior Director at Farragut Square Group, about the top priorities private equity investors should focus on under the Biden administration, including:
· How key government committees could shape healthcare legislation and the resulting impact on private equity investment
· Sectors that would most benefit from increased Medicaid support
· Changes to the proposed 2021 Medicare physician fee schedule
· Sectors offering private equity investors the biggest upside under the Biden administration
· Political power and potential pressure that accompanies Medicare Advantage
COVID-19 has catalyzed significant changes in the patterns of healthcare delivery, with the potential for long-lasting effects on payors as a result. On this episode of the After the Curve podcast, we discuss how the COVID-19 pandemic may shift the healthcare coverage and payment landscape as well as how it may boost integration among payors and providers. McDermott’s Chief Marketing Officer Leslie Tullio is joined by Kate McDonald and Ankur Goel to discuss relevant topics for both payers and the healthcare industry more broadly, including:
-
How COVID-19 is changing healthcare utilization patterns in the US and the impact of that disruption on insurers
-
The reaction from health plans to the financial impact of COVID-19 on providers
-
The impact of telehealth and regulatory waivers at the state and federal levels on the payor market
-
Top lessons that payors have learned from the pandemic and subsequent next steps
-
Opportunities for healthcare leaders to synthesize where we are today
-
Key takeaways for payors moving forward from the pandemic
Additional Resources:
After the Curve Report
McDermott Will & Emery
Healthcare Life Sciences News Blog
The lasting impact of COVID-19 on healthcare transactions is multifaceted and has rapidly altered the trajectory of the dealmaking landscape as well as business collaborations. On this episode of the After the Curve podcast, we discuss how the COVID-19 pandemic is affecting healthcare transactions today, as well as the outlook for the healthcare deal landscape post-COVID-19. McDermott’s Chief Marketing Officer Leslie Tullio is joined by Jed Spielman and Kevin Miller to discuss topics surrounding the impact of the pandemic on healthcare transactions, including:
-
The sectors of the healthcare industries that are most likely to experience a surge in deal volumes and why
-
COVID-19-induced programs that have altered the way healthcare transactions are getting done
-
Which transformational aspects of transaction protocol are most likely to carry into the post-COVID-19 future
-
Insights from the transactions perspective and a look at the most promising upcoming collaborations
-
Advice for dealmakers and healthcare leaders who are looking to effectively adjust their portfolios in a post-COVID-19 environment
Additional Resources:
After the Curve Report
McDermott Will & Emery
Healthcare Life Sciences News Blog
McDermott Health Law
COVID-19 led to major policy changes impacting how healthcare is delivered and reimbursed but only some of these new policies will endure in coming years. On this episode of the McDermott Health Podcast, we discuss how the regulatory landscape and enforcement priorities may shift in both the short and long term as we transition to the post-COVID-19 era. McDermott’s Chief Marketing Officer Leslie Tullio is joined by Monica Wallace and Emily Cook to discuss topics surrounding pandemic-induced regulatory and enforcement changes, including:
-
A definition of “robust” enforcement activity and how internal compliance teams can prepare to navigate that environment
-
Steps to take when preparing for audits in order to avoid enforcement actions
-
The importance of proper documentation in a rapidly changing environment
-
Current enforcement actions and government inquiries around the country and how to respond to them
-
Anticipated lessons learned from this pandemic and their impact on an organizational level
Additional Resources:
After the Curve Report
McDermott Will & Emery
Healthcare Life Sciences News Blog
McDermott Health Law
COVID-19 led to major policy changes impacting how healthcare is delivered and reimbursed but only some of these new policies will endure in the coming years. On this episode of the McDermott Health Podcast, we discuss how provider organizations can innovate their business models and care delivery to adapt and thrive in a post-COVID-19 world. McDermott’s Chief Marketing Officer Leslie Tullio is joined by Sandy DiVarco and Emily Cook to discuss topics surrounding the impact of the pandemic on healthcare provider organizations, including:
-
The value of government-provided playbooks for healthcare providers in national situations
-
Proper handling of the volume and dynamic nature of information that is conveyed to healthcare providers
-
The impact that the increased demand of telehealth will have on the industry from a regulatory perspective
-
The benefit of telehealth to hospitals and healthcare providers through the COVID-19 months and into the future
-
Key points leaders need to be aware of as the healthcare industry moves beyond the pandemic
Additional Resources:
After the Curve Report
McDermott Will & Emery
Healthcare Life Sciences News Blog
McDermott Health Law
In this time of crisis, the life science industry has demonstrated remarkable speed, innovation and resilience. In this episode of the After the Curve podcast, our life sciences partners join us to discuss the most promising areas of drug discovery and device development that are emerging from the pandemic and the outlook for the industry in a post-COVID-19 world. McDermott’s Chief Marketing Officer, Leslie Tullio, is joined by Stephen Bernstein and Kristian Werling to discuss key topics impacting the life sciences industry today.
In this time of crisis, the life science industry has demonstrated remarkable speed, innovation and resilience. On this episode of the After the Curve podcast, our life sciences partners join us to discuss the most promising areas of drug discovery and device development that are emerging from the pandemic and the outlook for the industry in a post-COVID-19 word. McDermott’s Chief Marketing Officer Leslie Tullio is joined by Stephen Bernstein and Kristian Werling to discuss key topics impacting the life sciences industry today, including:
-
The reasons behind the immunity of life sciences to slowed investments
-
Why more investors are focusing their equity in healthcare and life sciences
-
Promising areas of drug discovery and device development emerging from the pandemic
-
Critical considerations for life science companies regarding rapid regulatory changes
-
Tactics for moving developments forward at an increased speed
-
The importance of Collaborative Transformation to the life sciences industry
Additional Resources:
After the Curve Report
McDermott Will & Emery
Healthcare Life Sciences News Blog
McDermott Life Sciences
COVID-19 led to major policy changes impacting how healthcare is delivered and reimbursed but only some of these new policies will endure in coming years. On this episode of the McDermott Health Podcast, our colleagues from McDermott+Consulting join us to discuss how the pandemic has changed the conversation leading up to the November presidential election and how key policy issues will evolve in the months and years to come. McDermott’s Chief Marketing Officer Leslie Tullio is joined by Eric Zimmerman, Mara McDermott and Jessica Roth to discuss topics surrounding the pandemic-induced policy shifts, including:
-
Highly-critical healthcare policy issues that need to be addressed immediately
-
The vulnerability of a fee-for-services payment system and the alternate direction policies are shifting toward
-
Repercussions of telehealth policy changes for Medicare beneficiaries
-
Consequences of consolidation on policy changes, legislation and the federal budget
-
Prioritized health policy objectives that healthcare stakeholders can expect to see from each presidential candidate
-
Additional transformational healthcare policies of note, including surprise billing and increased transparency
-
Steps that healthcare stakeholders need to take now to prepare for 2021
Additional Resources:
After the Curve Report
McDermott Will & Emery
Healthcare Life Sciences News Blog
McDermott+Consulting
COVID-19 has demanded a rapid shift in the world of telehealth and digital health, resulting in a global embracing of a telehealth and digital health system that is not yet fully developed. On this episode of the McDermott Health podcast, our digital health partners have joined to discuss the future of telehealth and use of digital tools to speed up care delivery and to improve outcomes in the wake of COVID-19, as well as the vital role of data readiness in reshaping the healthcare system. McDermott’s Chief Marketing Officer Leslie Tullio is joined by partners Stephen Bernstein and Lisa Mazur to examine current trends and potential changes to both telehealth as well as the broader digital health landscape.
COVID-19 has demanded a rapid shift in the world of telehealth and digital health, resulting in a global embracing of a telehealth and digital health system that is not yet fully developed. On this episode of the McDermott Health podcast, our digital health partners have joined to discuss the future of telehealth and use of digital tools to speed up care delivery and to improve outcomes in the wake of COVID-19, as well as the vital role of data readiness in reshaping the healthcare system. McDermott’s Chief Marketing Officer Leslie Tullio is joined by partners Stephen Bernstein and Lisa Mazur to examine current trends and potential changes to both telehealth as well as the broader digital health landscape, including:
-
The most impactful regulatory telehealth changes that have resulted from COVID-19
-
A look beyond telehealth to a paradigm shift in the broader digital health landscape
-
The impact that a more refined data exchange pathway could have on treatment during the next wave of COVID-19 or future pandemics
-
Meaningful collaborations that are currently happening in the digital health space
-
A look at innovations that are emerging from the demands of post-COVID-19 healthcare
-
Legal and regulatory compliance steps that still need to be taken to allow these telehealth programs to continue in the future
Additional Resources:
After the Curve Report
McDermott Will & Emery
Healthcare Life Sciences News Blog
Of Digital Interest Blog
Telehealth Transformation
Driving the Deal: Public Hospital M&A and Stakeholder Buy-In by McDermott Health Podcast Channel
The COVID-19 health law briefing you need for the week of June 8. This episode covers: >The Department of Health and Human Service’s announcement of more targeted Provider Relief Funds >Further guidance from CMS on reopening healthcare facilities >New opportunities for stakeholders to help shape healthcare delivery during and after the pandemic
The COVID-19 health law briefing you need for the week of June 1. This episode covers: > Provider Relief Fund update, including the bipartisan letter to the Department of Health and Human Services (HHS) requesting expedited distribution to healthcare provider and recent updates to the HHS FAQs on the Provider Relief Fund > Centers for Medicare and Medicare Services (CMS) Innovation Model Flexibilities update > The CMS Nursing Home Report, the first official tally of infections and deaths in nursing facilities due to COVID-19 in nursing facilities
Public hospitals have a uniquely open relationship to the communities they serve, which invites a level of transparency as they consider potential mergers and acquisitions. So what kind of M&A deal activity options are out there for public hospitals dealing with financial pressures, and how can parties navigate regulatory, financial and public opinion to get the deal done? In this episode of Collaborative Transformation podcast series, Rex Burgdorfer, managing director at Juniper Advisory, joins McDermott partner Megan Rooney to discuss: > The major trends driving public hospital M&A > How M&A can strengthen hospitals financially and the regulatory and external challenges contributing to financial pressures > Unique regulatory and financial challenges faced by public hospitals > Benefits of privatization in the hospital industry > The role public sentiment can play in public hospital transactions
The COIVD-19 health law briefing you need for the week of May 25. This episode covers: > Strategic plan from the Department of Health and Human Services Office of Inspector General > Provider Relief Fund FAQs > Republican and Democrat health information privacy bills > White paper on healthcare coverage expansion during the pandemic > HHS’s outline on testing capacity goals > HRSA funds awarded to tribal health organizations
The COVID-19 health law briefing you need for the week of May 18, 2020. This episode covers: > HEROES Act stimulus package and notable changes that health stakeholders should watch from the bill > President Trump's executive order to examine which regulation suspensions should be made permanent > HHS distributes provider relief funds to nursing homes > Additional funding dispersed for COVID-19 testing
May 15 Friday Newsflash | Coronavirus Health Law Briefing by McDermott Health Podcast Channel
May 8 Friday Newsflash | Coronavirus Health Law Briefing by McDermott Health Podcast Channel
May 1 Friday Newsflash | Coronavirus Health Law Briefing by McDermott Health Podcast Channel
April 24 Friday Newsflash | Coronavirus Health Law Briefing by McDermott Health Podcast Channel
April 17 Friday Newsflash | Coronavirus Health Law Briefing by McDermott Health Podcast Channel
April 10 Friday Newsflash | Coronavirus Health Law Briefing by McDermott Health Podcast Channel
The healthcare industry is facing significant disruption from new market entrants and technology innovations that have the potential to improve how healthcare is delivered. But how do you tell which innovative technologies and ventures will have a sustained and positive impact, and which are just noise? In this episode of the Collaborative Transformation podcast series, Lucia Savage, chief privacy and regulatory officer at Omada Health, joins McDermott partner Jennifer S. Geetter to discuss: > What it takes for disruption to be truly constructive in today’s dynamic market > The rise of mobile healthcare delivery and patient engagement, driven by technological advances and consumer expectations > The limits of the HIPAA regulatory framework and current reimbursement rules as they relate to digital health technologies > Tips for tapping into the growing digital health innovation community through strategic investment
Healthcare is facing a time of transformation as regulators, providers and other stakeholders take action to improve care coordination and increase the use of technology to deliver care. Hospital and health system innovation centers are increasingly acting as the catalyst to fuel growth and expansion through technology and data. In this episode of the Collaborative Transformation podcast series, McDermott partners Kerrin Slattery and Krist Werling discuss: > Opportunities for innovation centers and other collaborative arrangements in healthcare > Top regulatory and compliance challenges innovators face and ways to navigate them > Organizational and cultural issues for healthcare leaders to consider when making innovation a strategic priority > Investment structures and unique due diligence concerns to address when designing or investing in innovative deals > Key considerations when executing cross-border transactions in healthcare and life sciences
On this this episode of the Collaborative Transformation podcast series, European life sciences lawyers Emmanuelle Trombe (Paris) and Gary Howes (London) discuss top areas for global collaboration in the life sciences space, the role of technology companies and other new collaboration partners, hurdles to overcome when structuring deals across industries, navigating international data regulations, including GDPR and considerations for executing successful biotech and pharma deals. For more information on Collaborative Transformations, visit us at mwe.com/collaborativetransformation
In an environment of change and uncertainty, health and life sciences organizations are embracing new ways of engaging and working with partners from inside and outside the health sector through Collaborative Transformations. In this podcast, McDermott's health and life sciences partners Kerrin Slattery, Dale Van Demark and Charlie Buck discuss how the top market players are working to drive and deliver game-changing innovations and shape the future of health care through impactful deal making. (499 characters)
Listen to McDermott’s Digital Health Thought Leaders Share Their Perspectives on the proliferation of digital devices and what it means to the marketplace today.